Evaluation of the Novel Automated Anti-Tachycardia Pacing Algorithm Successfully Terminating Sustained Monomorphic Ventricular Tachycardia in an Electrophysiology Study

Int Heart J. 2022;63(3):633-638. doi: 10.1536/ihj.21-755.

Abstract

We report the usefulness of novel automated anti-tachycardia pacing (ATP) for ventricular tachycardia (VT) termination evaluated in an electrophysiology study. This intrinsic, automated ATP with an implanted cardiac resynchronization therapy-defibrillator successfully terminated the sustained VT, which had not been suppressed by repetitive burst pacing from the electrode catheter. The reproduction of programed pacing of the automated ATP by a right ventricular electrode catheter was effective in terminating VT, and this termination was absolute and reproducible. Further detailed assessment in an electrophysiology study could highlight the algorithm of the automated ATP and its possible benefit in terminating the reentrant VT.

Keywords: Catheter ablation; Implantable cardioverter-defibrillator.

MeSH terms

  • Adenosine Triphosphate
  • Algorithms
  • Cardiac Resynchronization Therapy*
  • Death
  • Electrophysiology
  • Humans
  • Tachycardia, Ventricular* / therapy

Substances

  • Adenosine Triphosphate